Evidence map›Paper›PMID 33704443›Full record

ArticleBrain : a journal of neurology2021

Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson's disease.

George E C Thomas, Angeliki Zarkali, Mina Ryten, Karin Shmueli, Ana Luisa Gil-Martinez, Louise-Ann Leyland, Peter McColgan, Julio Acosta-Cabronero, Andrew J Lees, Rimona S Weil

Open access · hybridAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 105 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

George E C ThomasDementia Research Centre, UCL, London, WC1N 3AR, UK.ORCID 0000-0001-6107-0326
Angeliki ZarkaliDementia Research Centre, UCL, London, WC1N 3AR, UK.ORCID 0000-0003-2808-072X
Mina RytenDepartment of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1B 5EH, UK.
Karin ShmueliDepartment of Medical Physics and Biomedical Engineering, Malet Place Engineering Building, UCL, London, WC1E 6BT, UK.
Ana Luisa Gil-MartinezDepartment of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1B 5EH, UK.
Louise-Ann LeylandDementia Research Centre, UCL, London, WC1N 3AR, UK.
Peter McColganHuntington's Disease Centre, UCL Institute of Neurology, London, WC1B 5EH, UK.
Julio Acosta-CabroneroTenoke Ltd., IdeaSpace South, Cambridge Biomedical Campus, Cambridge, CB2 0AH, UK.ORCID 0000-0003-1174-5983
Andrew J LeesReta Lila Weston Institute of Neurological Studies, London, WC1N 1PJ, UK.ORCID 0000-0002-2476-4385
Rimona S WeilDementia Research Centre, UCL, London, WC1N 3AR, UK.ORCID 0000-0002-5092-6325
UK Dementia Research Institute · GBGreat Ormond Street Hospital · GBHuntington's Disease Association · GBUniversity College London · GBWellcome Centre for Human Neuroimaging · GB

Funding

Medical Research Council MR/N008324/1Medical Research Council MR/N013867/1Wellcome Trust 205167/Z/16/Z
6 · The paper itself

Abstract

The mechanisms responsible for the selective vulnerability of specific neuronal populations in Parkinson's disease are poorly understood. Oxidative stress secondary to brain iron accumulation is one postulated mechanism. We measured iron deposition in 180 cortical regions of 96 patients with Parkinson's disease and 35 control subjects using quantitative susceptibility mapping. We estimated the expression of 15 745 genes in the same regions using transcriptomic data from the Allen Human Brain Atlas. Using partial least squares regression, we then identified the profile of gene transcription in the healthy brain that underlies increased cortical iron in patients with Parkinson's disease relative to controls. Applying gene ontological tools, we investigated the biological processes and cell types associated with this transcriptomic profile and identified the sets of genes with spatial expression profiles in control brains that correlated significantly with the spatial pattern of cortical iron deposition in Parkinson's disease. Gene ontological analyses revealed that these genes were enriched for biological processes relating to heavy metal detoxification, synaptic function and nervous system development and were predominantly expressed in astrocytes and glutamatergic neurons. Furthermore, we demonstrated that the genes differentially expressed in Parkinson's disease are associated with the pattern of cortical expression identified in this study. Our findings provide mechanistic insights into regional selective vulnerabilities in Parkinson's disease, particularly the processes involving iron accumulation.

Indexed as

AgedAged, 80 and overBrainFemaleHumansImage Interpretation, Computer-AssistedIronMagnetic Resonance ImagingMaleMiddle AgedNerve DegenerationNeuroimagingOxidative StressParkinson DiseaseTranscriptomeIrongeneticsironParkinson’s diseasequantitative susceptibility mappingtranscriptomics

Identifiers

PMID33704443
PMCPMC8320305
OpenAlexW3134259195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.